Outbound Investment

Multinational corporations with both a U.S. and China presence may increasingly find themselves caught between two legal systems as both countries implement regulations that seek to achieve diametrically opposite objectives. What are the issues and how should companies prepare and respond?

SEC starts 3-year timer for delisting 5 Chinese companies; further measures for enhancing financial stability; stronger protection for victims of domestic violence

Crypto-fundraising criminally outlawed; Delisting process to be streamlined and modernized; Controversial anti-spying initiative comes to an end

2021 regulatory trends in China, including antitrust, data privacy, sanctions, healthcare, PE/VC, capital markets, IP, banking & finance, TMT and arbitration.

Regulation of platform economy to focus on anti-trust, data security, and personal information protection; U.S. might ban import of rare earth metals from China for military use; new process to expedite application of certain trademarks

With the entrenchment of reciprocal US-China sanctions and export controls in the past year, counsel have helped clients enact fundamental changes to their approach to making deals, from contractual terms to due diligence

Public outrage at Canada Goose's discriminatory return policy; SEC rules implement submission and disclosure requirements for U.S.-listed foreign companies; e-cigarettes to be regulated as a tobacco product

BRI projects face a multiplicity of issues from procurement to implementation. Investors must thoroughly understand and mitigate risks associated with BRI ventures.

The U.S. adds 12 Chinese entities to its export blacklist; Rules regulating listed companies to be consolidated; Didi ordered by regulators to delist from NYSE